Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Today's News. Tomorrow's Perspective. Today's News. Tomorrow's Perspective.

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.

Today's News. Tomorrow's Perspective. Today's News. Tomorrow's Perspective.

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.

  • Home
  • Breaking News
  • Business
  • Sports
  • Health
  • Politics
  • Technology & AI
  • World
  • Home
  • Breaking News
  • Business
  • Sports
  • Health
  • Politics
  • Technology & AI
  • World
Close

Search

Subscribe
Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people
Health

Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people

Stephen Atcheler
By Stephen Atcheler
November 17, 2026 4 Min Read
Comments Off on Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people

NEWYou can now listen to Fox News articles!

Three antidepressants may be more effective than fluoxetine, widely known by the brand name Prozac, in helping people with depression improve and stay healthy over time, a new study suggests.

The research, published in The Lancet Psychiatry, compared 20 antidepressants to see how well they eased symptoms of depression and helped prevent them from coming back over time.

Researchers analyzed 115 previous clinical trials involving more than 30,000 people, according to a press release from Radboud University Medical Center in the Netherlands.

SOME SLEEP HABITS MAY OFFER CLUES TO A HIDDEN TYPE OF DEPRESSION, SCIENTISTS SAY

They discovered that escitalopram, sold under the brand name Lexapro; duloxetine, sold under the name Cymbalta; and agomelatine had better long-term results than fluoxetine, which the researchers used as the main comparison drug.

Eli Lilly told Fox News Digital that it has stopped manufacturing Prozac in 2024. The company noted that fluoxetine remains available in many FDA-approved generic drugs and that neither the study nor the university’s press release specifically referred to Prozac or any Lilly product.

Man holding blood pressure medication

A new study suggests that three antidepressants may be more effective than fluoxetine in helping people recover from depression and stay healthy over time. (iStock)

The findings suggest that antidepressants may continue to help patients after their symptoms improve, although some medications appear to work better than others in keeping patients well.

Paul van Haaren, a researcher at Radboud University Medical Center who worked on the study, noted that the three drugs have different advantages and disadvantages.

CLICK HERE FOR MORE HEALTH STORIES

“Escitalopram is already widely used,” he said in the release. “Agomelatine works well, but one of its side effects is the risk of liver failure. Duloxetine is less known and is less frequently prescribed as first line.”

Escitalopram belongs to a common group of antidepressants called selective serotonin reuptake inhibitors, or SSRIs. These medications are often recommended as a first option for treating depression, according to the release.

Man holding medicine bottle in one hand and pill in the other

Researchers compared antidepressant treatments to better understand which medications can help patients maintain improvements and prevent depression symptoms from returning. (iStock)

Of the SSRIs included in the study, escitalopram appears to be the most effective in helping patients stay healthy over time.

Eric Ruhé, professor of difficult-to-treat depression at Radboud University Medical Center, said the findings could eventually influence how doctors choose antidepressants. However, the researchers stressed that this does not mean that everyone with depression should take escitalopram.

CLICK HERE TO SUBSCRIBE TO OUR HEALTH NEWSLETTER

“As a prescriber, you think about the balance between the benefits and side effects of a medication,” Ruhé said in the release. “This balance differs from person to person.”

Dr. Carole Lieberman, a board-certified psychiatrist based in Beverly Hills, Calif., who was not involved in the study, urged caution in interpreting the results.

Woman taking pill

Escitalopram, duloxetine, and agomelatine appear to outperform fluoxetine in maintaining long-term improvement in depression symptoms. (iStock)

She noted that agomelatine is not approved in the United States.

“The best way to treat someone with depression is not always with antidepressants, and certainly not just antidepressants,” Lieberman told Fox News Digital.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Psychotherapy or talk therapy can also play an important role in treating depression, according to Lieberman, while some patients may benefit from using medication as an adjunct to therapy.

The study had some limitations, the researchers acknowledged.

Woman receiving in-person therapy

The researchers cautioned that the results cannot predict which antidepressant will work best for a specific patient, highlighting the need for individualized treatment decisions. (iStock)

Rather than recruiting a new group of patients and following them over time, the researchers combined results from 115 previous clinical trials to compare the drugs’ performance.

The results also cannot predict which antidepressant will work best for a specific person. The researchers emphasized that doctors and patients should consider both potential benefits and side effects when choosing a drug.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

People with questions about their antidepressants should talk to their doctor before changing their treatment, according to the release.

Fox News Digital has reached out to the researchers and other drugmakers for comment.

Kelly McGreal is a member of the lifestyle team at Fox News Digital. She and her team cover travel, food & drink, health, relationships and much more. She also produces the weekly American Culture Quiz and manages other special projects.

Gn Health

Views: 4
Stephen Atcheler
Author

Stephen Atcheler

**Stephen** is a staff journalist at **DailyVoxa**, specializing in business, finance, technology, artificial intelligence, and global markets. He is committed to delivering timely, accurate, and insightful reporting that helps readers understand the forces shaping the global economy and the rapidly evolving digital landscape.Drawing on in-depth research and credible sources, Stephen covers breaking developments, industry trends, and emerging innovations with a focus on clarity, balance, and factual accuracy. His reporting is designed to provide readers with reliable information, practical context, and thoughtful analysis without sensationalism.As a member of the DailyVoxa editorial team, Stephen follows the publication's Editorial Policy, Fact-Checking Policy, Corrections Policy, and Ethics Policy. Every article is carefully reviewed to ensure it meets the highest standards of journalistic integrity, transparency, and editorial independence.

Follow Me
Other Articles
The Next Bond Girl: From Zendaya to Florence Pugh, 19 actresses who could join Robert Pattinson - Variety
Previous

The Next Bond Girl: From Zendaya to Florence Pugh, 19 actresses who could join Robert Pattinson – Variety

Saleh: Titans give Cam Ward more opportunities
Next

Saleh: Titans give Cam Ward more opportunities

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.
  • About Us
  • Accessibility Statement
  • Advertise With Us
  • AI Usage & Transparency Policy
  • Contact us
  • Cookie Policy
  • Corrections Policy
  • Meet Our Team
  • Privacy Policy
    • Disclaimer
    • DMCA & Copyright Policy
    • Editorial Policy
    • Ethics Policy
    • Fact-Checking Policy
  • Terms and Conditions
Copyright 2026 — Today's News. Tomorrow's Perspective.. All rights reserved.